0001127602-13-014783.txt : 20130430 0001127602-13-014783.hdr.sgml : 20130430 20130430172517 ACCESSION NUMBER: 0001127602-13-014783 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130426 FILED AS OF DATE: 20130430 DATE AS OF CHANGE: 20130430 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SCOTT DAVID J CENTRAL INDEX KEY: 0001145154 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-12477 FILM NUMBER: 13799161 MAIL ADDRESS: STREET 1: AMGEN INC. STREET 2: ONE AMGEN CENTER DRIVE CITY: THOUSAND OAKS STATE: CA ZIP: 91320-1799 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AMGEN INC CENTRAL INDEX KEY: 0000318154 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 953540776 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE AMGEN CENTER DRIVE CITY: THOUSAND OAKS STATE: CA ZIP: 91320 BUSINESS PHONE: (805)447-1000 MAIL ADDRESS: STREET 1: ONE AMGEN CENTER DRIVE CITY: THOUSAND OAKS STATE: CA ZIP: 91320 FORMER COMPANY: FORMER CONFORMED NAME: AMGEN DATE OF NAME CHANGE: 19870305 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2013-04-26 0000318154 AMGEN INC AMGN 0001145154 SCOTT DAVID J ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320-1799 1 SVP, Gen. Counsel & Secy. Common Stock 2013-04-26 4 F 0 757 108.66 D 76281 D Common Stock 2013-04-28 4 F 0 744 108.38 D 75537 D These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 1,450 RSUs which fully vest on 4/26/2014; 22,081 RSUs which fully vest on 12/31/2014; 7,504 RSUs which vest in one installment of 3,696 on 4/25/2014 and one installment of 3,808 on 4/25/2015; 6,141 RSUs which vest in three installments of 2,026, 2,027 and 2,088 on 4/27/2014, 4/27/2015 and 4/27/2016, respectively; and 5,374 RSUs which vest in two equal installments of 1,773 each on 1/28/2015 and 1/28/2016 and one installment of 1,828 on 1/28/2017. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. These shares include 142 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. /s/ Andrea Robinson, Attorney-in-Fact for Mr. Scott 2013-04-30